why choose us

First received: January 19, 2023

Clinical Trial: ALBI and PALBI Scores and HCC Prognosis

Study Status: Completed

Recruit Status: Completed

Condition: Hepatocellular Carcinoma (HCC) Prognosis

Study Type: Observational


Official Title: Assessment of Prognostic Accuracy of Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades in Hepatocellular Carcinoma Patients According to Different Treatment Modalities

Brief Summary: To compare the predictive ability of ALBI and PALBI grades with CTP and MELD scores.To investigate the efficacy of ALBI and PALBI grades for predicting the prognosis of HCC and overall survival among different modalities of treatment.

Read more